Evelo Biosciences (EVLO) Competitors $0.0005 0.00 (0.00%) As of 08/15/2025 11:08 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock EVLO vs. SYRS, VRPX, SCPS, CMRA, GNCAQ, GNCA, ARDS, CALA, STAB, and AMPEShould you be buying Evelo Biosciences stock or one of its competitors? The main competitors of Evelo Biosciences include Syros Pharmaceuticals (SYRS), Virpax Pharmaceuticals (VRPX), Scopus BioPharma (SCPS), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Calithera Biosciences (CALA), Statera Biopharma (STAB), and Ampio Pharmaceuticals (AMPE). These companies are all part of the "pharmaceutical products" industry. Evelo Biosciences vs. Its Competitors Syros Pharmaceuticals Virpax Pharmaceuticals Scopus BioPharma Comera Life Sciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals Calithera Biosciences Statera Biopharma Ampio Pharmaceuticals Evelo Biosciences (NASDAQ:EVLO) and Syros Pharmaceuticals (NASDAQ:SYRS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership. Do analysts rate EVLO or SYRS? Syros Pharmaceuticals has a consensus target price of $1.00, indicating a potential upside of 62,400.00%. Given Syros Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Syros Pharmaceuticals is more favorable than Evelo Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evelo Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Syros Pharmaceuticals 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders hold more shares of EVLO or SYRS? 0.3% of Evelo Biosciences shares are held by institutional investors. Comparatively, 91.5% of Syros Pharmaceuticals shares are held by institutional investors. 1.0% of Evelo Biosciences shares are held by insiders. Comparatively, 12.3% of Syros Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is EVLO or SYRS more profitable? Evelo Biosciences' return on equity of 0.00% beat Syros Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Evelo BiosciencesN/A N/A N/A Syros Pharmaceuticals N/A -3,369.56%-97.04% Does the media prefer EVLO or SYRS? In the previous week, Syros Pharmaceuticals had 1 more articles in the media than Evelo Biosciences. MarketBeat recorded 1 mentions for Syros Pharmaceuticals and 0 mentions for Evelo Biosciences. Syros Pharmaceuticals' average media sentiment score of 1.00 beat Evelo Biosciences' score of 0.00 indicating that Syros Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Evelo Biosciences Neutral Syros Pharmaceuticals Positive Which has stronger earnings & valuation, EVLO or SYRS? Evelo Biosciences has higher earnings, but lower revenue than Syros Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvelo BiosciencesN/AN/A-$114.53MN/AN/ASyros Pharmaceuticals$386K0.11-$164.57M-$3.030.00 Which has more volatility & risk, EVLO or SYRS? Evelo Biosciences has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, Syros Pharmaceuticals has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. SummarySyros Pharmaceuticals beats Evelo Biosciences on 8 of the 11 factors compared between the two stocks. Get Evelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EVLO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVLO vs. The Competition Export to ExcelMetricEvelo BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$9K$778.25M$5.73B$9.79BDividend YieldN/A4.84%3.90%4.13%P/E RatioN/A1.1622.3123.74Price / SalesN/A25.64444.16106.04Price / CashN/A19.5625.2228.44Price / BookN/A6.599.255.96Net Income-$114.53M-$4.67M$3.26B$265.21M7 Day PerformanceN/A3.22%7.39%4.22%1 Month PerformanceN/A3.30%4.22%0.77%1 Year PerformanceN/A15.26%30.30%24.69% Evelo Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVLOEvelo BiosciencesN/A$0.00flatN/AN/A$9KN/A0.00120SYRSSyros Pharmaceuticals4.3875 of 5 stars$0.00flat$3.33+302,930.3%-99.9%$30K$386K0.00120Positive NewsShort Interest ↓Gap DownVRPXVirpax PharmaceuticalsN/A$0.01flatN/A-99.9%$14KN/A0.007SCPSScopus BioPharmaN/A$0.00flatN/AN/A$13KN/A0.009High Trading VolumeCMRAComera Life SciencesN/A$0.00flatN/AN/A$6K$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6KN/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6K$1.91M0.0070ARDSAridis PharmaceuticalsN/A$0.00flatN/AN/A$5KN/A0.0030High Trading VolumeCALACalithera Biosciences0.599 of 5 stars$0.00flatN/A-92.0%$5KN/A0.0060STABStatera BiopharmaN/A$0.00flatN/AN/A$5KN/A0.0020AMPEAmpio PharmaceuticalsN/A$0.00flatN/A+22.7%$3KN/A0.0020 Related Companies and Tools Related Companies SYRS Alternatives VRPX Alternatives SCPS Alternatives CMRA Alternatives GNCAQ Alternatives GNCA Alternatives ARDS Alternatives CALA Alternatives STAB Alternatives AMPE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVLO) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access